Fenofibric Acid Patent Expiration

Fenofibric Acid is Used for managing elevated cholesterol levels and hyperlipidemias in patients through adjunctive therapy alongside diet. It was first introduced by Athena Bioscience Llc in its drug Fibricor on Aug 14, 2009.


Fenofibric Acid Patents

Given below is the list of patents protecting Fenofibric Acid, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Fibricor US7569612 Methods of use of fenofibric acid Aug 20, 2027 Athena
Fibricor US7741373 Methods of use of fenofibric acid Aug 20, 2027 Athena
Fibricor US7741374 Methods of use of fenofibric acid Aug 20, 2027 Athena
Fibricor US7915247 Methods of use of fenofibric acid Aug 20, 2027 Athena



Fenofibric Acid's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List